Rhoshan Pharmaceuticals is an early stage life sciences company with one program in clinical development. With enhanced versions of existing drugs, we provide essential early treatment to the acute leading causes of death. We expect FDA approval for our lead product in 2027.

Rhoshan Pharmaceuticals provides pharmaceutical research and drug development services; clinical research and testing services in the fields of pharmaceuticals; scientific research and development services; drug discovery services.